Pages that link to "Q34363450"
Jump to navigation
Jump to search
The following pages link to Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain (Q34363450):
Displaying 50 items.
- Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects (Q22248075) (← links)
- Detection of dopaminergic supersensitivity induced by neuroleptic drugs in mice (Q28260250) (← links)
- Effects of estrogens on the characteristics of [3H]spiroperidol and [3H]RU24213 binding in rat anterior pituitary gland and brain (Q28319229) (← links)
- Clozapine decreases enkephalin mRNA in rat striatum (Q28320961) (← links)
- 3H-catecholamine binding to α-receptors in rat brain: Enhancement by reserpine (Q28322102) (← links)
- Effects of continuous exposure to light on behavioral dopaminergic supersensitivity (Q28378021) (← links)
- Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity (Q28593050) (← links)
- Behavioral and neurobiological changes in C57BL/6 mouse exposed to cuprizone: effects of antipsychotics. (Q30482602) (← links)
- Neurochemical brain imaging investigations of schizophrenia (Q30581142) (← links)
- Effect of chronic olanzapine treatment on striatal synaptic organization (Q31544744) (← links)
- Striatal dopamine D2 receptors in tardive dyskinesia: PET study (Q33627591) (← links)
- Increased dopamine transmission in schizophrenia: relationship to illness phases (Q33679807) (← links)
- Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies (Q33833648) (← links)
- Current hypotheses on sigma receptors and their physiological role: possible implications in psychiatry (Q33921280) (← links)
- A neurochemical basis for the antipsychotic activity of loxapine: interactions with dopamine D1, D2, D4 and serotonin 5-HT2 receptor subtypes (Q33921663) (← links)
- Astrocyte line SVG-TH grafted in a rat model of Parkinson's disease (Q33939090) (← links)
- Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs (Q34338202) (← links)
- Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus (Q34377109) (← links)
- L-Type Ca(2+) channels are essential for glutamate-mediated CREB phosphorylation and c-fos gene expression in striatal neurons (Q34377561) (← links)
- Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia (Q34383654) (← links)
- Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders (Q34509861) (← links)
- "Breakthrough" dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time (Q34577698) (← links)
- Altered probabilistic learning and response biases in schizophrenia: Behavioral evidence and neurocomputational modeling (Q34631789) (← links)
- Investigational drugs for schizophrenia targeting the dopamine receptor: phase II trials (Q34703195) (← links)
- No Evidence for an Association between Dopamine D2 Receptor Polymorphisms and Tardive Dyskinesia in Korean Schizophrenia Patients (Q34811987) (← links)
- Can antipsychotic drugs be classified by their effects on a particular group of dopamine neurons in the brain? (Q34998394) (← links)
- Oxidative mechanisms and tardive dyskinesia (Q35017644) (← links)
- Annual Research Review: New frontiers in developmental neuropharmacology: can long-term therapeutic effects of drugs be optimized through carefully timed early intervention? (Q35046638) (← links)
- Mind molecules (Q35065098) (← links)
- Targeting the dopamine receptor in schizophrenia: investigational drugs in Phase III trials (Q35071909) (← links)
- Trajectories of brain development: point of vulnerability or window of opportunity? (Q35121756) (← links)
- The therapeutic potential of CRF1 antagonists for anxiety (Q35814456) (← links)
- Striatal dopamine receptor plasticity in neurotensin deficient mice (Q35834247) (← links)
- The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussin toxin (Q35874821) (← links)
- Effects of a common variant in the CD38 gene on social processing in an oxytocin challenge study: possible links to autism (Q35892745) (← links)
- Dopamine receptor turnover rates in rat striatum are age-dependent (Q36263669) (← links)
- The behavioral actions of lithium in rodent models: leads to develop novel therapeutics (Q36293345) (← links)
- Agonist-induced subsensitivity of adenylate cyclase coupled with a dopamine receptor in slices from rat corpus striatum (Q36305183) (← links)
- Regulation of dopamine- and adenosine-dependent adenylate cyclase systems of chicken embryo retina cells in culture (Q36312874) (← links)
- Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans (Q36666227) (← links)
- An examination of sex differences in the effects of early-life opiate and alcohol exposure (Q36672409) (← links)
- Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model (Q36727004) (← links)
- Neurobiology of dopamine in schizophrenia (Q36756356) (← links)
- Genetic underpinnings of tardive dyskinesia: passing the baton to pharmacogenetics (Q37264543) (← links)
- Cholinergic activity regulates muscarinic receptors in central nervous system cultures (Q37341241) (← links)
- Increased abundance of alternatively spliced forms of D2 dopamine receptor mRNA after denervation (Q37462990) (← links)
- Septal deafferentation increases hippocampal adrenergic receptors: correlation with sympathetic axon sprouting (Q37550241) (← links)
- Effects of repeated treatment with the dopamine D2/D3 receptor partial agonist aripiprazole on striatal D2/D3 receptor availability in monkeys (Q37672380) (← links)
- Modulation of receptor mechanisms in the CNS: Hyper-and hyposensitivity to catecholamines (Q37818979) (← links)
- Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism (Q37983747) (← links)